Parenteral Fish Oil in Sepsis

Completed

• Conditions: Systemic inflammatory response syndrome/sepsis; Infections and Infestations; Other septicaemia

• Registration Number: ISRCTN89432944
• Lead Sponsor: Hospital Padre Americo (Portugal)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2009-11-17
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

1. Systemic inflammatory response syndrome or sepsis
2. Predicted to need parenteral nutrition
3. Assigned to ICU
4. Over 18 years of age, either sex

Exclusion Criteria

1. Able to be enterally fed
2. Under 18 years of age

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Plasma phospholipid fatty acid status at days 0, 1, 2 and 6<br>2. Plasma inflammatory cytokines at days 0, 1, 2 and 6<br>3. Inflammatory cytokine production by endotoxin stimulated whole blood at days 0, 1, 2 and 6<br>4. Length of ICU and hospital stay

Secondary Outcome Measures

Name	Time	Method
1. Respiratory function at days 0, 1, 2 and 6<br>2. Mortality up to day 28